retatrutide phase 3 trial dosage Safety, Side Effects & Provider Use Lilly's retatrutide shows 28% weight

Cost remains a major hurdle for GLP-1 users

Shao J, Liu X, Lian M, Mao Y

What is Medical Weight Loss & GLP-1 Therapy

4 In a rigorous trial involving over 17,600 participants, Wegovy significantly reduced the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke

Mattsson K, Nilsson-Condori E, Elmerstig E, et al

These medications help by: Increasing insulin production when needed Slowing stomach emptying Reducing hunger signals Promoting feelings of fullness Because of these effects, GLP-1 drugs have become widely prescribed for both diabetes management and weight loss